Forbion

Investor type

VC

Founded

2006

AUM

$5 000 M

Location

Naarden, North Holland, Netherlands

Investment Ticket

$10-50 m

Investment Stage

Seed Series B

Region of investment

Europe
Investor profile last updated: 16 August, 2026

Profile

Forbion is a leading global venture capital firm with deep expertise in Europe. We invest in innovative biotech companies, managing just over €5 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. In addition, we leverage our biotech expertise beyond human health to address ‘planetary health’ challenges through our BioEconomy fund strategy, which invests in companies developing sustainable solutions in food, agriculture, materials, and environmental technologies.

Industry

HealthTech MedTech Pharmaceuticals Medical Devices Financial Services Fintech Healthcare Services Biotechnology Robotics Life Sciences Food and Beverage Foodtech Fashion/Beauty SaaS Software Transportation Sports/SportsTech Energy

Forbion Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Forbion Growth Opportunities Fund I
Fund of funds
Food and Beverage
Foodtech
Healthcare Services
Robotics
HealthTech
Seed
Series A
Series B
North America
Europe
$5-10 m
$360 M
April 2021
Forbion Growth Opportunities Fund II
Fund of funds
Fashion/Beauty
Food and Beverage
Foodtech
Healthcare Services
Robotics
SaaS
Software
Transportation
HealthTech
Seed
Series A
Series B
North America
Europe
$5-10 m
$470 M
June 2022
Forbion Ventures Fund VI
Venture Capital (VC)
Fashion/Beauty
Food and Beverage
Foodtech
Robotics
SaaS
Sports/SportsTech
Energy
Pre-seed
Seed
North America
Europe
$5-10 m
$750 M
April 2023
Forbion Ventures Fund VII
Venture Capital (VC)
Fashion/Beauty
Food and Beverage
Foodtech
Healthcare Services
Robotics
Sports/SportsTech
Energy
HealthTech
Pre-seed
Seed
North America
Europe
$5-10 m
$890 M
October 2024

Contacts

Name
Title
Email
avatar
Dr. Dmitrij Hristodorov General Partner
General Partner
d•••@•••
avatar
Joy Faucher General Partner
General Partner
j•••@•••
Upgrade to see contacts
avatar
LtPvuTJ9XWY1gEMy LtPvuTJ9XWY1gEMy
LtPvuTJ9XWY1gEMy
avatar
LtPvuTJ9XWY1gEMy LtPvuTJ9XWY1gEMy
LtPvuTJ9XWY1gEMy
avatar
LtPvuTJ9XWY1gEMy LtPvuTJ9XWY1gEMy
LtPvuTJ9XWY1gEMy
Investment-team contacts for Forbion — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Forbion

Forbion is a venture capital firm. It backs companies at Seed and Series B, writing tickets of $10-50 m.
Forbion is located in Naarden, North Holland, Netherlands.
Forbion was founded in 2006.
Forbion invests in companies and startups in HealthTech, MedTech, Pharmaceuticals, Medical Devices, Financial Services, Fintech, Healthcare Services, Biotechnology, Robotics, Life Sciences, Food and Beverage, Foodtech, Fashion/Beauty, SaaS, Software, Transportation, Sports/SportsTech, Energy.
Forbion invests in companies and startups in Europe.
Forbion invests in companies and startups at Seed, Series B.
Forbion usually invests $10-50 m on average.
Forbion has around $5 000m assets under management.
Forbion last fund was created/launched in 2024-10-24
Forbion can be reached through its website forbion.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Forbion — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Forbion directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.